Bedlack discusses ALS "X-Files" in Nature
In the absence of medical treatments that can slow or stop the disease, patients with amyotrophic lateral sclerosis (ALS) are often tempted to turn to alternative therapies. While these therapies are unproven, some of the patients taking them occasionally improve. In the latest issue of Nature, Rick Bedlack, MD, PhD, discusses his efforts to unravel what is causing these "ALS reversals"--whether there are ALS-mimicking diseases, people with a rare ability to recover from ALS, or whether certain therapies can make a difference. Read his full commentary, which also includes a discussion of his ALS Untangled project, here.